Search

COVID-19 vaccines represent a step towards ending the pandemic and getting back to a sense of normalcy after enduring more than a year of isolation, social distancing, and other measures to control the spread of the coronavirus.

… Thursday, May 20, 2021 Nassau County resident receives literature from MSK nurse Nassau County resident Farrah Mozawalla receives literature from MSK nurse Curt Haase prior to receiving her second dose of the COVID-19 vaccine. MSK nurse Curt Haase administers the vaccine MSK nurse Curt Haase administers

Learn how researchers are making better CAR T cells by taking a lesson from viruses.

… Thursday, January 30, 2025 CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient’s own immune T cells and engineering them to recognize specific targets on the surface of the cancer cell. A major limitation of this type of CAR

Memorial Sloan Kettering Cancer Center researchers have identified a feature in the DNA of breast cancer cells that might indicate the likelihood a woman's disease will become life threatening.

… Friday, July 1, 2011 Summary Memorial Sloan Kettering Cancer Center researchers have identified a feature in the DNA of breast cancer cells that might indicate the likelihood a woman’s disease will become life threatening. Memorial Sloan Kettering Cancer Center researchers have identified a feature in

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, March 28, 2024 Vittoria Bocchi, Melissa Yao, Julia Brunner, and Tzippora Chwat-Edelstein Awarded 2024 Kravis WiSE Fellowships 2024 Marie-Josée Kravis Women in Science Endeavor (WiSE) fellowship winners Vittoria Bocchi, PhD , postdoctoral fellow,  Julia Brunner, PhD , postdoctoral fellow,  Melissa

Renowned cancer biologist Joan Massagué, PhD, has been named Director of the Sloan Kettering Institute, one of the most dynamic and robust cancer research programs in the United States, and the research arm of Memorial Sloan Kettering Cancer Center.

… Monday, November 25, 2013 Renowned cancer biologist Joan Massagué, PhD , has been named Director of the Sloan Kettering Institute , one of the most dynamic and robust cancer research programs in the United States, and the research arm of Memorial Sloan Kettering Cancer Center. Dr. Massagué, Chair of

There is concern that mastectomy is over-utilized in the United States, which raises questions about the role of surgeons and patient preference in treatment selection for breast cancer. New data from an observational study published in the October 14 issue of the Journal of the American Medical Association, a theme issue on surgical care, found that breast-conserving surgery was presented and provided in the majority of patients evaluated.

… Tuesday, October 13, 2009 Breast-Conserving Surgery Offered to the Majority of Patients There is concern that mastectomy is over-utilized in the United States, which raises questions about the role of surgeons and patient preference in treatment selection for breast cancer . New data from an observational

A new study by investigators at Memorial Sloan Kettering Cancer Center (MSK) found no evidence of an increased risk of biochemical recurrence with any PDE5 inhibitor use or duration in the first year following radical prostatectomy.

… Tuesday, March 5, 2024 There have been conflicting studies on whether phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil or tadalafil, are associated with an increased risk of biochemical recurrence after radical prostatectomy for prostate cancer. A new study by investigators at Memorial

An MSK geriatrician discusses the importance of helping older people with cancer manage their treatment and symptoms.

… Tuesday, July 9, 2019 Summary Older people with cancer are especially vulnerable to health setbacks during and after treatment. MSK geriatrician Armin Shahrokni explains how monitoring symptoms closely can reduce the risk of serious problems that require a hospital stay. Memorial Sloan Kettering geriatrician

Three young investigators who have made major accomplishments in cancer research will be the recipients of the 2007 Paul Marks Prize for Cancer Research and will share a $150,000 award, announced Memorial Sloan Kettering Cancer Center (MSKCC).

… Wednesday, September 26, 2007 Biennial Award Honors Investigators Who Have Made Important Contributions to the Biological Understanding of Cancer Three young investigators who have made major accomplishments in cancer research will be the recipients of the 2007 Paul Marks Prize for Cancer Research and

Learn about the experiences and accomplishments of the 2014 Gerstner Sloan Kettering Summer Undergraduate Research Program students during their ten-week course of study.

… Friday, September 12, 2014 Our 2014 Summer Undergraduate Research Program (SURP) came to an end on August 8 after a stimulating and successful summer. Twenty-four students were immersed in the scientific community at Memorial Sloan Kettering,  strengthening their basic research skills and giving them